After launching a partnership in 2015, GSK and Propellor Health have announced an expanded collaboration focused on commercial activities surrounding the use of the Propeller clip-on sensor and software platform for with GSK’s ELLIPTA Inhaler.
The clip-on sensor for the ELLIPTA Inhaler automatically records medication use, which the Propeller platform analyzes and presents to patients and physicians through its interface.
The expanded collaboration follows the late-2016 CE marking and US FDA 510(k) class II clearance of the Propeller sensor and software program for the GSK inhaler.
Read the press release